Intra-Cellular Stock Price History Breakdown

ITCI
 Stock
  

USD 52.53  1.04  1.94%   

As of today, the current price of Intra-Cellular Ther is  52.53 , as last reported on the 15th of August 2022, with the highest price reaching  54.20  and the lowest price hitting  51.24  during the day.
Intra-Cellular Ther holds Efficiency (Sharpe) Ratio of -0.0477, which attests that the entity had -0.0477% of return per unit of risk over the last 3 months. Macroaxis standpoint towards determining the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. Intra-Cellular Ther exposes twenty-eight different technical indicators, which can help you to evaluate volatility that cannot be diversified away. Please be advised to check out Intra-Cellular Ther Downside Deviation of 2.9, risk adjusted performance of 0.0292, and Market Risk Adjusted Performance of 0.0858 to validate the risk estimate we provide.
  
The current Net Income Common Stock is estimated to decrease to about (291.6 M). The current Price to Sales Ratio is estimated to increase to 52.08, while Price to Book Value is projected to decrease to 8.15. Intra-Cellular Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Most Recent Activity

Shares Float
87.4 M
Shares Outstanding
94.4 M
Shares Short Prior Month
3.7 M
Earnings Share
-3.61
Shares Short
3.3 M
Revenue Per Share
1.58

Intra-Cellular Ther August 15, 2022 Stock Price Synopsis

Intra-Cellular Ther Accumulation Distribution 61,432 
Intra-Cellular Ther Price Action Indicator(0.71) 
Intra-Cellular Ther Price Rate Of Daily Change 0.98 
Intra-Cellular Ther Price Daily Balance Of Power(0.35) 

Intra-Cellular Ther August 15, 2022 Stock Price Analysis

Share Download
When benchmark price declines in a down market, there may be an uptick in Intra-Cellular Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Intra-Cellular Ther intraday prices and daily technical indicators to check the level of noise trading in Intra-Cellular Stock and then apply it to test your longer-term investment strategies against Intra-Cellular.

Intra-Cellular Ther Stock Price History Chart

There are several ways to analyze Intra-Cellular Stock price data. The simplest method is using a basic Intra-Cellular candlestick price chart, which shows Intra-Cellular Ther price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

90 Days Highest PriceAugust 5, 202259.99
90 Days Lowest PriceAugust 1, 202251.72

Intra-Cellular Stock Price History Data

The price series of Intra-Cellular Ther for the period between Tue, May 17, 2022 and Mon, Aug 15, 2022 has a statistical range of 8.27 with a coefficient of variation of 3.6. Under current investment horizon, the daily prices are spread out with arithmetic mean of 56.15. The median price for the last 90 days is 56.17.
OpenHighLowCloseVolume
08/15/2022 53.09  54.20  51.24  52.53  1,124,864 
08/12/2022 57.02  57.35  52.86  53.57  1,478,861 
08/11/2022 58.90  59.83  56.01  57.02  911,600 
08/10/2022 57.30  59.45  57.02  59.19  602,900 
08/09/2022 56.23  60.00  55.03  56.33  919,100 
08/08/2022 59.00  59.82  56.85  58.85  1,648,500 
08/05/2022 58.05  61.00  56.08  59.99  1,434,600 
08/04/2022 56.06  58.91  56.06  58.77  831,400 
08/03/2022 55.99  57.87  55.40  56.20  778,700 
08/02/2022 52.09  55.33  51.98  55.26  906,600 
08/01/2022 53.88  54.12  51.37  51.72  651,800 
07/29/2022 54.29  54.48  52.95  54.12  554,500 
07/28/2022 53.79  54.47  52.19  54.21  500,700 
07/27/2022 52.94  54.32  52.87  53.49  396,100 
07/26/2022 53.24  54.35  52.99  53.25  344,000 
07/25/2022 55.61  55.77  52.11  53.02  868,200 
07/22/2022 56.40  56.93  55.03  55.67  451,000 
07/21/2022 56.78  56.87  54.46  55.81  479,500 
07/20/2022 55.91  57.28  55.36  56.50  582,300 
07/19/2022 55.00  57.89  54.38  55.93  542,700 
07/18/2022 55.68  56.77  53.90  54.19  493,600 
07/15/2022 56.30  56.40  53.58  55.25  501,100 
07/14/2022 53.00  56.20  52.26  55.95  613,400 
07/13/2022 53.78  55.61  53.26  53.39  615,200 
07/12/2022 55.09  56.04  53.27  54.47  359,700 
07/11/2022 57.22  57.54  53.40  55.40  707,100 
07/08/2022 57.07  58.56  56.59  57.57  471,000 
07/07/2022 57.34  59.16  56.85  58.01  710,300 
07/06/2022 57.19  59.75  54.97  56.17  752,500 
07/05/2022 54.50  57.29  53.17  57.09  475,300 
07/01/2022 56.67  57.12  53.13  55.17  896,500 
06/30/2022 57.48  58.79  56.29  57.08  792,700 
06/29/2022 56.02  58.97  54.84  58.31  628,200 
06/28/2022 57.89  58.99  55.10  55.23  710,200 
06/27/2022 56.20  59.04  55.97  57.90  763,800 
06/24/2022 57.83  58.51  55.26  55.62  1,600,400 
06/23/2022 53.44  57.74  53.44  57.19  813,300 
06/22/2022 54.00  55.85  53.13  54.27  647,500 
06/21/2022 55.11  56.92  54.73  54.82  968,700 
06/17/2022 53.91  58.55  53.91  54.94  1,606,100 
06/16/2022 54.93  56.09  52.78  53.43  692,500 
06/15/2022 54.56  57.57  53.76  56.53  927,400 
06/14/2022 53.55  54.50  51.98  54.02  535,700 
06/13/2022 51.23  53.88  51.12  53.07  942,800 
06/10/2022 54.85  54.85  51.23  53.02  685,700 
06/09/2022 57.24  57.87  55.26  55.48  392,900 
06/08/2022 58.21  59.35  56.08  57.61  481,200 
06/07/2022 57.95  60.00  57.95  58.79  425,500 
06/06/2022 58.88  59.82  58.11  58.20  571,900 
06/03/2022 55.24  59.96  55.11  58.35  548,300 
06/02/2022 55.08  56.07  53.91  55.66  618,500 
06/01/2022 57.47  58.50  54.80  55.26  511,300 
05/31/2022 57.86  58.73  56.83  57.40  581,200 
05/27/2022 57.48  58.92  54.59  58.28  719,600 
05/26/2022 57.14  59.30  56.70  58.72  516,900 
05/25/2022 56.75  56.75  55.55  56.67  689,700 
05/24/2022 57.90  58.33  55.88  56.96  544,400 
05/23/2022 58.67  58.96  57.35  58.41  609,700 
05/20/2022 58.50  59.85  55.55  57.88  873,800 
05/19/2022 58.75  60.64  57.39  57.73  930,900 

About Intra-Cellular Ther Stock history

Intra-Cellular Ther investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Intra-Cellular is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Intra-Cellular Ther will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Intra-Cellular Ther historical stock prices may prove useful in developing a viable investing in Intra-Cellular Ther
Last ReportedProjected for 2022
Weighted Average Shares81.3 M66.4 M
Weighted Average Shares Diluted81.3 M66.5 M
Issuance Purchase of Equity Shares11.5 M11.8 M
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. Intra-Cellular Therapies, Inc. was founded in 2002 and is headquartered in New York, New York. Intra-Cellular Ther operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 512 people.

Intra-Cellular Ther Quarterly Market Capitalization

5.38 Billion

Intra-Cellular Ther Stock Technical Analysis

Intra-Cellular Ther technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Intra-Cellular Ther technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Intra-Cellular Ther trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Portfolio Volatility Now

   

Portfolio Volatility

Check portfolio volatility and analyze historical return density to properly model market risk
All  Next Launch Module

Intra-Cellular Ther Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Intra-Cellular stock's direction in advance. Along with the technical and fundamental analysis of Intra-Cellular Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Intra-Cellular to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen stock market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Please see Risk vs Return Analysis. Note that the Intra-Cellular Ther information on this page should be used as a complementary analysis to other Intra-Cellular Ther's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Complementary Tools for Intra-Cellular Stock analysis

When running Intra-Cellular Ther price analysis, check to measure Intra-Cellular Ther's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intra-Cellular Ther is operating at the current time. Most of Intra-Cellular Ther's value examination focuses on studying past and present price action to predict the probability of Intra-Cellular Ther's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Intra-Cellular Ther's price. Additionally, you may evaluate how the addition of Intra-Cellular Ther to your portfolios can decrease your overall portfolio volatility.
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Is Intra-Cellular Ther's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intra-Cellular Ther. If investors know Intra-Cellular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intra-Cellular Ther listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
5.1 B
Quarterly Revenue Growth YOY
1.77
Return On Assets
-0.28
Return On Equity
-0.5
The market value of Intra-Cellular Ther is measured differently than its book value, which is the value of Intra-Cellular that is recorded on the company's balance sheet. Investors also form their own opinion of Intra-Cellular Ther's value that differs from its market value or its book value, called intrinsic value, which is Intra-Cellular Ther's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intra-Cellular Ther's market value can be influenced by many factors that don't directly affect Intra-Cellular Ther's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intra-Cellular Ther's value and its price as these two are different measures arrived at by different means. Investors typically determine Intra-Cellular Ther value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intra-Cellular Ther's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.